Acabal, Joan .

HRN: 23-99-08  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/02/2023
CEFUROXIME 1.5GM (VIAL)
12/02/2023
12/08/2023
IV
1.5
Q8
Uti
Waiting Final Action 
12/03/2023
CEFUROXIME 1.5GM (VIAL)
12/03/2023
12/03/2023
IV
1.5gram
1 More Dose
S/p Primary CS
Waiting Final Action 
12/03/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
12/03/2023
12/05/2023
IV
500mg
X 4 More Doses
S/p Primary CS
Waiting Final Action 
12/04/2023
METRONIDAZOLE 500MG (TAB)
12/04/2023
12/10/2023
PO
500mg
TID
CS
Waiting Final Action 
12/04/2023
CEFUROXIME 500MG (TAB)
12/04/2023
12/10/2023
PO
500mg
BID
Cs
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: